Osseointegrated Transtibial Implants in Patients with Peripheral Vascular Disease A Multicenter Case Series of 5 Patients with 1-Year Follow-up

Osseointegrated Transtibial Implants in Patients with Peripheral Vascular Disease A Multicenter Case Series of 5 Patients with 1-Year Follow-up
复制标题

DOI:
10.2106/jbjs.16.01295
复制
发表时间:
2017-09-20
影响因子:
5.3
通讯作者:
Al Muderis, Munjed
Al Muderis, Munjed
中科院分区:
医学1区
文献类型:
--
作者:
Atallah, Robin;Li, Jiao Jiao;Al Muderis, Munjed

文献摘要

被引文献

相似文献

背景:骨整合是一种替代治疗截肢者谁是无法佩戴或有困难的承窝假体。虽然大多数截肢是由于血管疾病,这种截肢已被视为骨整合手术的禁忌症。我们报告了5例外周血管疾病截肢患者的骨整合重建结果:对2014年至2015年接受骨整合植入物的5例经胫骨截肢和外周血管疾病病史的患者进行了12个月的随访。评估临床和功能结局,包括疼痛、患者佩戴假体的时间、活动度、行走能力和生活质量。不良事件,包括感染,骨折,植入失败,翻修手术,额外截肢,和death,进行了监测和recorded.Results:5 transtibial截肢者(56至84岁),随后为1年后,骨整合手术被列入本病例系列。随访时所有患者的活动度均得到改善。3名患者在手术前坐轮椅,但所有5名患者在随访时都能够行走和进行日常活动。术后12个月,5例患者中有4例无疼痛,所有5例患者均使用骨整合假体。两名患者有一个单一的发作浅表软组织infection.Conclusions:骨整合种植体可能被认为是一个可行的替代传统的插座假体周围血管疾病的患者。
Background: Osseointegration is an alternative treatment for amputees who are unable to wear or have difficulty wearing a socket prosthesis. Although the majority of limb amputations are due to vascular disease, such amputations have been perceived as a contraindication to osseointegration surgery. We report the outcomes of osseointegrated reconstruction in a series of 5 patients with limb amputation due to peripheral vascular disease.Methods: Five patients with transtibial amputation and a history of peripheral vascular disease who received an osseointegration implant from 2014 to 2015 were followed for 12 months. Clinical and functional outcomes were assessed, including pain, the amount of time the patient wore the prosthesis, mobility, walking ability, and quality of life. Adverse events, including infection, fracture, implant failure, revision surgery, additional amputation, and death, were monitored and recorded.Results: Five transtibial amputees (56 to 84 years of age) followed for 1 year after osseointegration surgery were included in this case series. The mobility of all patients was improved at the time of follow-up. Three patients were wheelchair-bound prior to the surgery but all 5 were able to walk and perform daily activities at the time of follow-up. Four of the 5 patients were pain-free at 12 months postoperatively, and all 5 were using the osseointegrated prosthesis. Two patients had a single episode of superficial soft-tissue infection.Conclusions: An osseointegrated implant may be considered a feasible alternative to the conventional socket prosthesis for patients with peripheral vascular disease.